Raymond James & Associates’s UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN MLPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-10,091
Closed -$508K 2496
2015
Q1
$508K Sell
10,091
-7,174
-42% -$373K ﹤0.01% 2036
2014
Q4
$993K Buy
+17,265
New +$1.09M ﹤0.01% 1582

Other funds holding MLPL

Raymond James & Associates's MLPL Position: Q2 2015 in Review

Raymond James & Associates sold out of UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN (MLPL) in Q2 2015, closing a stake of 10,091 shares — an estimated $508K sold.

Raymond James & Associates first reported a position in MLPL in Q4 2014 and held it in 2 quarters. The position peaked at $993K in Q4 2014. 21 funds tracked by Wall St. Rank hold MLPL as of Q2 2015.

  • Raymond James & Associates reported no remaining UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position as of Q2 2015 after selling out during the quarter.
  • Raymond James & Associates sold 10,091 UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN shares in Q2 2015, an estimated $508K.
  • Raymond James & Associates first reported a position in UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN in Q4 2014 and held it in 2 quarters.
  • Raymond James & Associates's UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position peaked at $993K in Q4 2014.
  • 21 funds tracked by Wall St. Rank held UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN as of Q2 2015.

Based on Raymond James & Associates's 13F filing for Q2 2015, filed 13 Aug 2015.